[Epidemiologic followup of cases of tuberculosis in the medical-social centers of Paris for the year 1994].
This study was carried out in 280 patients in 1994 in five medico-social centres (CMS) in the city of Paris for the follow up of treatment tuberculous disease. The group represented approximately one fifth of the tuberculous patients in Paris. 90.7% of the subjects were of foreign origin, predominantly African. Amongst these 280 patients, 80% were unemployed and 64.6% without social security protection. Their tuberculous disease did not differ on clinical grounds from those of the general population but they were less often vaccinated with BCG. They are also less often co-infected with the HIV virus (4.4 vs 12-16%). The level of resistance to isoniazid and rifampicin was 1.4%. A cure was certainly achieved in 73.5% of the patients. For the remainder, the absence of information and the loss to follow up prevented us from having a definite answer. The patients lost to follow numbered 56 and represented 20% of the group.
Antoun
F
F
CMS Edison Direction de l'Action Sociale, de l'Enfance et de la Santé, Paris.
Momas
I
I
Vieu
V
V
Poinsard
R
R
Crespy
M
M
D000293:Adolescent; D000328:Adult; D000349:Africa / Q000208:ethnology; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000453:epidemiology; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D017057:Medically Uninsured; D008875:Middle Aged; D010297:Paris / Q000453:epidemiology; D011159:Population Surveillance; D012293:Rifampin / Q000627:therapeutic use; D012943:Social Security; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000208:ethnology; D014478:Unemployment; D014611:Vaccination / Q000706:statistics & numerical data
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D001500:BCG Vaccine; D007538:Isoniazid; D012293:Rifampin
Suivi épidémiologique des cas de tuberculose dans les centres médico-sociaux de Paris pour l'année 1994.